SCHEMBL30210705

SCHEMBL30210705

Nc1c(Cl)ccc2ccncc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 1/20 0.49
DYRK1A Q13627 1/20 0.49
IMPDH2 P12268 3/20 0.47
GAA P10253 1/20 0.47
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42
RAD52 P43351 1/20 0.42
MAPK10 P53779 1/20 0.41
EGFR P00533 1/20 0.39
MAP4K1 Q92918 1/20 0.39
MAPT P10636 2/20 0.38
PRKCZ Q05513 1/20 0.38
TNF P01375 1/20 0.38
CSNK1A1 P48729 1/20 0.38
CSNK1D P48730 1/20 0.38
CSNK1E P49674 1/20 0.38
CSNK1G2 P78368 1/20 0.38
CSNK1G1 Q9HCP0 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11736164 1.00 CLK1 (0.49) CLK1DYRK1AIMPDH2GAAKDM4E
SCHEMBL6794058 0.79 CYP2A6 (0.50) CLK1DYRK1AIMPDH2GAAKDM4E
Hydrochloric Acid SCHEMBL11737866 0.78 CYP2A6 (0.48) CLK1DYRK1AIMPDH2GAAKDM4E
SCHEMBL27040501 0.76 IMPDH2 (0.43) CLK1DYRK1AIMPDH2GAAKDM4E
SCHEMBL11743241 0.76 CLK1 (0.41) CLK1DYRK1AIMPDH2GAAKDM4E
SCHEMBL10921238 0.76 IMPDH2 (0.72) CLK1DYRK1AIMPDH2GAAKDM4E
SCHEMBL27332884 0.76 EP300 (0.53) CLK1DYRK1AIMPDH2KDM4EPOLB
SCHEMBL31586019 0.75 MAP4K1 (0.41) IMPDH2GAAMAP4K1CYP3A4
SCHEMBL672509 0.75 CLK1 (0.54) CLK1DYRK1AIMPDH2KDM4EPOLB
SCHEMBL29569821 0.75 CLK1 (0.54) CLK1DYRK1AIMPDH2KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11566003-B2 Isoquinolines as inhibitors of HPK1 GENENTECH, INC. (US) 2023-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11566003-B2 Isoquinolines as inhibitors of HPK1 HIPK1, HIPK2, IP6K1 CLK1 29/4885DYRK1A 1204/4885IMPDH2 782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.